听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览PHARMACOTHERAPY期刊下所有文献
  • Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.

    abstract:STUDY OBJECTIVE:To evaluate the effect of acarbose on glycemic control and glycemic variability, using a continuous glucose-monitoring system, in patients with type 2 diabetes mellitus who were not well controlled on metformin and vildagliptin therapy. DESIGN:Multicenter, randomized, double-blind, placebo-controlled s...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1648

    authors: Derosa G,Franzetti I,Querci F,D'Angelo A,Maffioli P

    更新日期:2015-11-01 00:00:00

  • Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program.

    abstract::Our objective was to describe the implementation and clinical outcomes of an employer-sponsored, pharmacist-provided medication therapy management (MTM) program for health plan beneficiaries with diabetes mellitus and/or hypertension. We conducted a single-center retrospective medical record review. The setting was a ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1650

    authors: Theising KM,Fritschle TL,Scholfield AM,Hicks EL,Schymik ML

    更新日期:2015-11-01 00:00:00

  • Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram-Positive Infections.

    abstract::Health care-associated infections, especially those caused by multidrug-resistant gram-positive organisms, such as methicillin-resistant Staphylococcus aureus (MRSA), are a growing public health threat. In 2014, the U.S. Food and Drug Administration approved two new lipoglycopeptides, oritavancin and dalbavancin, for ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1641

    authors: Roberts KD,Sulaiman RM,Rybak MJ

    更新日期:2015-10-01 00:00:00

  • Extracorporeal Elimination of Piperacillin/Tazobactam during Molecular Adsorbent Recirculating System Therapy.

    abstract::Use of the Molecular Adsorbent Recirculating System (MARS) as a liver support device continues to grow worldwide. Various components of the MARS circuit remove both protein-bound and water-soluble molecules. Little is known about the extent of the enhanced clearance mechanisms used in MARS therapy on drug elimination....

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1618

    authors: Personett HA,Larson SL,Frazee EN,Nyberg SL,El-Zoghby ZM

    更新日期:2015-08-01 00:00:00

  • Spontaneous Hemopericardium in a Patient Receiving Apixaban Therapy: First Case Report.

    abstract::Apixaban, a direct factor Xa inhibitor, is a novel oral anticoagulant (NOAC) indicated for prevention of embolic events in patients with nonvalvular atrial fibrillation. The agent is associated with a lower risk of bleeding compared with vitamin K antagonists such as warfarin. Hemopericardium is a life-threatening ble...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1602

    authors: Sigawy C,Apter S,Vine J,Grossman E

    更新日期:2015-07-01 00:00:00

  • Alfuzosin treatment improves the rate and time for stone expulsion in patients with distal uretral stones: a prospective randomized controlled study.

    abstract:OBJECTIVE:To evaluate the safety and efficacy of alfuzosin treatment on rate and time of stone expulsion in patients with uncomplicated distal ureteral stones. PATIENTS AND METHODS:Prospective, randomized, open-label, controlled study. Patients > 18 years of age presenting to the outpatient urology clinic with uncompl...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/phar.1593

    authors: El Said NO,El Wakeel L,Kamal KM,Morad Ael R

    更新日期:2015-05-01 00:00:00

  • Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.

    abstract::Staphylococcus aureus (S. aureus) has proven to be a major pathogen with the emergence of methicillin-resistant S. aureus (MRSA) infections and recently with heteroresistant vancomycin-intermediate S. aureus (hVISA) and vancomycin-intermediate S. aureus (VISA) infections. Although vancomycin is traditionally a first-l...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1577

    authors: Gomes DM,Ward KE,LaPlante KL

    更新日期:2015-04-01 00:00:00

  • Efficacy of triclosan as an antimicrobial hand soap and its potential impact on antimicrobial resistance: a focused review.

    abstract::Triclosan is a synthetic biocide found in many household products, including antimicrobial hand soap. Levels of triclosan have been found throughout the environment and in human urine, blood, and even breast milk. Increasing levels of exposure to triclosan have led to concerns over the development of resistance to tri...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1553

    authors: Giuliano CA,Rybak MJ

    更新日期:2015-03-01 00:00:00

  • Recent advances in the development of specific antidotes for target-specific oral anticoagulants.

    abstract::Warfarin, a vitamin K antagonist, has been the only orally available anticoagulant for > 60 years. During the past decade, the U.S. Food and Drug Administration has approved several target-specific oral anticoagulants (TSOACs) for the prophylaxis and treatment of arterial and venous thromboembolism and stroke preventi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1532

    authors: Mo Y,Yam FK

    更新日期:2015-02-01 00:00:00

  • Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy.

    abstract::Disseminated herpes simplex virus (HSV) infection in neonates represents a devastating entity that yields high mortality. Acyclovir is the primary antiviral agent used to treat life-threatening HSV infections in neonates; however, even though the agent has reduced morbidity overall from these infections, mortality wit...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1526

    authors: Cies JJ,Moore WS 2nd,Miller K,Small C,Carella D,Conley S,Parker J,Shea P,Chopra A

    更新日期:2015-02-01 00:00:00

  • Colistin: understanding and applying recent pharmacokinetic advances.

    abstract::Colistin, the most widely used polymyxin antibiotic, was originally introduced in the late 1950s before the establishment of the present-day drug approval process. Originally shelved due to toxicity concerns, colistin, in the form of its inactive prodrug colistin methanesulfonate, has undergone a renaissance in the pa...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1484

    authors: Ortwine JK,Kaye KS,Li J,Pogue JM

    更新日期:2015-01-01 00:00:00

  • Adverse reactions associated with systemic polymyxin therapy.

    abstract::The systemic polymyxins, colistin and polymyxin B, are increasingly used for multidrug-resistant bacterial infections and have a long history of dose-limiting toxicity. This review summarizes the most recent available information about the mechanisms, incidence, risk factors, and minimization strategies for polymyxin ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1493

    authors: Justo JA,Bosso JA

    更新日期:2015-01-01 00:00:00

  • Susceptibility testing of the polymyxins: where are we now?

    abstract::Antimicrobial susceptibility testing for the polymyxins-colistin and polymyxin B-is fraught with technical challenges. Key among these is the propensity of the polymyxins to adsorb to polystyrene, a material often used for in vitro minimum inhibitory concentration testing devices. This effect may be mitigated by the a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1505

    authors: Humphries RM

    更新日期:2015-01-01 00:00:00

  • Successful use of tetrabenazine in a patient with intractable hiccups after stroke.

    abstract::A hiccup is a myoclonic jerk of the diaphragm, and cases of hiccups may last for more than 48 hours (persistent hiccups) or even more than 2 months (intractable hiccups). Current pharmacologic treatment of persistent or intractable hiccups mainly includes antidopaminergic drugs. We describe the case of a 60-year-old m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1523

    authors: Naro A,Bramanti P,Calabrò RS

    更新日期:2014-12-01 00:00:00

  • How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.

    abstract:STUDY OBJECTIVE:To review quantitatively and qualitatively the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) database to provide clinicians with a general understanding of the comparative occurrence of clinically meaningful adverse events associated with 15 antimicrobial new molecular en...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1519

    authors: Khadem TM,van Manen RP,Brown J

    更新日期:2014-12-01 00:00:00

  • Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.

    abstract::Antimicrobial resistance among gram-positive organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) continues to limit therapeutic options. The oxazolidinones are a synthetic class of agents now commonly relied on for the treatment of serious MRSA and VRE infect...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1491

    authors: Rybak JM,Marx K,Martin CA

    更新日期:2014-11-01 00:00:00

  • Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.

    abstract:STUDY OBJECTIVE:To assess the reproducibility of Naranjo Adverse Drug Reaction Probability Scale (APS) scores in published case reports. DESIGN:Reliability analysis. MEASUREMENTS AND MAIN RESULTS:Randomly selected case reports using the APS were identified from the Web of Science database. The APS scores were blinded...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1496

    authors: Liang R,Borgundvaag B,McIntyre M,Thwaites C,Ragan K,Wyllie A

    更新日期:2014-11-01 00:00:00

  • Sublingual administration of tacrolimus: current trends and available evidence.

    abstract::Widespread anecdotal use of sublingual tacrolimus administration has arisen, although little literature exists to guide practice. Given the paucity of data, we conducted a survey to evaluate the practice of sublingual tacrolimus administration at transplant centers across the United States and evaluated the literature...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1492

    authors: Doligalski CT,Liu EC,Sammons CM,Silverman A,Logan AT

    更新日期:2014-11-01 00:00:00

  • Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.

    abstract::Bedaquiline is a diarylquinoline antitubercular drug with a novel mechanism of action against Mycobacterium tuberculosis. Bedaquiline works by inhibiting bacterial adenosine triphosphate (ATP) synthase and represents the first novel class of antituberculosis agents in more than 40 years. Bedaquiline is indicated for t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1482

    authors: Worley MV,Estrada SJ

    更新日期:2014-11-01 00:00:00

  • Postoperative atrial fibrillation: role of inflammatory biomarkers and use of colchicine for its prevention.

    abstract::Postoperative atrial fibrillation (POAF) is the most common complication following cardiac surgery, occurring in up to 65% of cardiac surgical patients. It is a condition associated with increased morbidity, increased length of hospital stay, and increased health care costs. One of the many potential causes of POAF is...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1485

    authors: Worden JC,Asare K

    更新日期:2014-11-01 00:00:00

  • Emerging roles for pharmacists in clinical implementation of pharmacogenomics.

    abstract::Pharmacists are uniquely qualified to play essential roles in the clinical implementation of pharmacogenomics. However, specific responsibilities and resources needed for these roles have not been defined. We describe roles for pharmacists that emerged in the clinical implementation of genotype-guided clopidogrel ther...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1481

    authors: Owusu-Obeng A,Weitzel KW,Hatton RC,Staley BJ,Ashton J,Cooper-Dehoff RM,Johnson JA

    更新日期:2014-10-01 00:00:00

  • Physician-pharmacist collaborative management of asthma in primary care.

    abstract:OBJECTIVE:To determine if asthma control improves in patients who receive physician-pharmacist collaborative management (PPCM) during visits to primary care medical offices. DESIGN:Prospective pre-post study of patients who received the intervention in primary care offices for 9 months. The primary outcome was the sum...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1468

    authors: Gums TH,Carter BL,Milavetz G,Buys L,Rosenkrans K,Uribe L,Coffey C,MacLaughlin EJ,Young RB,Ables AZ,Patel-Shori N,Wisniewski A

    更新日期:2014-10-01 00:00:00

  • National evaluation of prescriber drug dispensing.

    abstract:OBJECTIVE:To describe the legal, professional, and consumer status of prescribers dispensing legend and over-the-counter drugs in the United States. METHODS:Legal and academic databases were searched to identify those states that permit prescribers to dispense medications to patients and any limitations on such practi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1461

    authors: Munger MA,Ruble JH,Nelson SD,Ranker L,Petty RC,Silverstein S,Barton E,Feehan M

    更新日期:2014-10-01 00:00:00

  • Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.

    abstract::The U.S. population continues to experience an alarmingly high rate of unintended pregnancies that have an impact on individual families and society alike. Lack of effective contraception accounts for most unintended pregnancies, along with incorrect use of contraceptives. The most common reversible contraceptive meth...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1457

    authors: Rafie S,McIntosh J,Shealy KM,Borgelt LM,Forinash A,Shrader SP,Koepf ER,McClendon KS,Griffin BL,Horlen C,Karaoui LR,Rowe EL,Lodise NM,Wigle PR

    更新日期:2014-09-01 00:00:00

  • Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval.

    abstract:STUDY OBJECTIVE:Evaluate dabigatran adverse event reports with a reported bleeding event and/or reported fatal outcome compared with warfarin. DESIGN:Retrospective analysis of the FDA Adverse Event Reporting System (FAERS) database. MEASUREMENTS AND MAIN RESULTS:We identified reports from October 1, 2010, through Dec...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1415

    authors: McConeghy KW,Bress A,Qato DM,Wing C,Nutescu EA

    更新日期:2014-06-01 00:00:00

  • Carfilzomib-associated tumor lysis syndrome.

    abstract::Multiple myeloma is the second most common type of hematologic malignancy. It is a B-cell malignancy that affects the bone marrow and often results in thrombocytopenia as well as renal dysfunction. Treatment options range from oral and intravenous chemotherapy to bone marrow transplantation and supportive care. Carfil...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1397

    authors: Shely RN,Ratliff PD

    更新日期:2014-05-01 00:00:00

  • The promising impact of ibrutinib, a Bruton's tyrosine kinase inhibitor, for the management of lymphoid malignancies.

    abstract::Lymphoid malignancies comprise a heterogeneous group of disorders originating from clonal proliferation of B or T lymphocytes. Treatment of lymphoid neoplasms has traditionally been pursued with cytotoxic chemotherapy. To improve efficacy and ameliorate the adverse effects associated with classic chemotherapy, molecul...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1366

    authors: Bhatt V,Alejandro L,Michael A,Ganetsky A

    更新日期:2014-03-01 00:00:00

  • PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.

    abstract:STUDY OBJECTIVE:To assess the relationship of the 33 single nucleotide polymorphisms (SNPs) previously associated with fasting glucose in Caucasians in genome-wide association studies (GWAS) with glucose response to antihypertensive drugs shown to increase risk for hyperglycemia and diabetes. DESIGN:Randomized, multic...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1355

    authors: Gong Y,McDonough CW,Beitelshees AL,Karnes JH,O'Connell JR,Turner ST,Chapman AB,Gums JG,Bailey KR,Boerwinkle E,Johnson JA,Cooper-DeHoff RM

    更新日期:2014-02-01 00:00:00

  • Efficacy of topical atorvastatin for the treatment of pressure ulcers: a randomized clinical trial.

    abstract:STUDY OBJECTIVE:To evaluate the effects of topical atorvastatin on the healing process of pressure ulcers in critically ill patients. DESIGN:Randomized, double-blind, placebo-controlled clinical trial. SETTING:Medical-surgical intensive care unit of a university-affiliated teaching hospital in Tehran, Iran. PATIENTS...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/phar.1339

    authors: Farsaei S,Khalili H,Farboud ES,Karimzadeh I,Beigmohammadi MT

    更新日期:2014-01-01 00:00:00

  • Comparison of prescription drug costs in the United States and the United kingdom, part 4: antibiotics in young children.

    abstract:OBJECTIVES:To compare the usage and cost of antibiotics in the United States and United Kingdom in children younger than 10 years. METHODS:A follow up of some 160,000 young children enrolled in U.S. private health insurance companies and an equal number in general practices in the United Kingdom in 2009, based on two ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1387

    authors: Jick H,Wilson A,Chamberlin D

    更新日期:2014-01-01 00:00:00

  • Preparing clinical pharmacy scientists for careers in clinical/translational research: can we meet the challenge?: ACCP Research Affairs Committee Commentary.

    abstract::Developing clinical pharmacists' research skills and their ability to compete for extramural funding is an important component of the American College of Clinical Pharmacy's (ACCP) vision for pharmacists to play a prominent role in generating the new knowledge used to guide patient pharmacotherapy. Given the recent em...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1348

    authors: Parker RB,Ellingrod V,DiPiro JT,Bauman JL,Blouin RA,Welage LS

    更新日期:2013-12-01 00:00:00

  • Utilization of coagulation assays in clinical therapeutics.

    abstract::With the emergence of new anticoagulants, clinicians need a thorough understanding of coagulation assays. Various laboratory assays exist to measure the effectiveness of anticoagulants. Coagulation assays are the primary method for measuring the effectiveness of anticoagulants; therefore, a comprehensive understanding...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1283

    authors: Peters GL,Erwin PB,Pitlick MK,Stacy ZA

    更新日期:2013-11-01 00:00:00

  • Patient satisfaction with services provided by multidisciplinary anticoagulation clinics.

    abstract:STUDY OBJECTIVE:To assess patients' perception of care delivery by anticoagulation clinics (ACs) throughout Alberta, Canada. DESIGN:Prospective postal survey. SETTING:Therapy provision by an AC to ambulatory-based patients for a minimum of 3 months across the province. PATIENTS:A total of 1687 patients (67.9%) recei...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1002/phar.1318

    authors: Bungard TJ,Barry AR,Jones C,Brocklebank C

    更新日期:2013-11-01 00:00:00

  • Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancer.

    abstract:STUDY OBJECTIVE:To determine if development of acneiform rash is a predictor of objective response rate with lapatinib. DESIGN:Subanalysis of data from a prospective, phase II study. SETTING:Academic breast care clinic. PATIENTS:Forty-nine treatment-naïve patients with human epidermal growth factor receptor-2 (HER2)...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1308

    authors: Parma J,Pavlick A,Schiff R,Osborne CK,Chang JC,Rimawi M,Trivedi MV

    更新日期:2013-10-01 00:00:00

  • Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.

    abstract::In patients infected with chronic hepatitis B virus (HBV) that goes untreated, therapeutic options are limited once the disease decompensates, and orthotopic liver transplantation is often the only treatment available to save the patient's life. After liver transplantation, combined therapy with hepatitis B immune glo...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1306

    authors: McGonigal KH,Bajjoka IE,Abouljoud MS

    更新日期:2013-09-01 00:00:00

  • Institutional review board barriers and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: a national multicenter practice-based implementation trial.

    abstract:STUDY OBJECTIVE:To categorize institutional review board (IRB) challenges and solutions encountered in a multicenter practice-based research network (PBRN) study and to assess the impact of IRB requirements on the willingness of individual principal investigators (PIs) to participate in future PBRN studies. DESIGN:Des...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1276

    authors: Maclaughlin EJ,Ardery G,Jackson EA,Ives TJ,Young RB,Fike DS,Carter BL

    更新日期:2013-09-01 00:00:00

  • Ceftaroline-induced eosinophilic pneumonia.

    abstract::We present a case of eosinophilic pneumonia due to ceftaroline used for the treatment of methicillin-resistant Staphylococcus aureus bacteremia associated with a postoperative spinal infection. Our patient developed shortness of breath and hypoxemia on the fifth week of ceftaroline therapy. Chest imaging disclosed dif...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1286

    authors: Desai KR,Burdette SD,Polenakovik HM,Hagaman J,Pleiman CM

    更新日期:2013-07-01 00:00:00

  • Key articles and guidelines in the primary prevention of ischemic stroke.

    abstract::Ischemic stroke is a prevalent disease with a large burden on the health system. Preventive strategies, therefore, are paramount. Primary prevention is aimed at reducing the risk of stroke in asymptomatic people. The most effective prevention is through control of modifiable risk factors. Due to the large amount of li...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.1255

    authors: Baker WL,Marrs JC,Davis LE,Nutescu EA,Rowe AS,Ryan M,Splinter MY,Vardeny O,Fagan SC

    更新日期:2013-06-01 00:00:00

  • Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.

    abstract::Hypoactive sexual desire disorder (HSDD) affects nearly 1 in 10 women. Thus, it is essential for pharmacists and other health care providers to be comfortable when discussing a patient's sexual health to ensure appropriate triage so that the specific causes of HSDD can be identified and potential recommendations provi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1209

    authors: Lodise NM

    更新日期:2013-04-01 00:00:00

  • Severe hypoglycemia from Helicobacter pylori triple-drug therapy and insulin detemir drug interaction.

    abstract::Two drugs commonly used in triple-drug therapy for treatment of a Helicobacter pylori infection, clarithromycin and omeprazole, have rarely been associated with hypoglycemia when given alone. No documented interactions between H. pylori treatment with clarithromycin, amoxicillin, and omeprazole and insulin detemir hav...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1228

    authors: Otsuka SH

    更新日期:2013-04-01 00:00:00

512 条记录 3/13 页 « 12345678...1213 »